Trip is a UK-founded functional beverage and wellness brand best known for its calming sparkling drinks infused with CBD, magnesium, adaptogens and botanicals such as L-theanine, ashwagandha, lemon balm and chamomile. Founded in 2019 by husband-and-wife team Olivia Ferdi (CEO) and Daniel Khoury after Khoury used CBD to recover from a serious knee injury before their wedding, the brand has grown into the UK's leading calming drinks company and the sixth-largest carbonated drinks brand in the country. Trip's product range has expanded beyond CBD to include magnesium-led drinks, mocktails, gummies, oils and powders, and the company has built a viral following on TikTok where it is one of the top-selling drink brands. Distribution spans more than 50,000 doors globally, including Sainsbury's, Boots, Ocado, Waitrose, Asda, Selfridges and Soho House in the UK, and Target, Sprouts, Whole Foods Market, H-E-B, Wegmans, CVS and Erewhon in the United States, where it has partnered with meditation app Calm. In November 2025 Trip raised $40 million at a $300 million valuation in a round led by Coefficient Capital with backing from celebrity investors including Joe Jonas, Alessandra Ambrosio, Paul Wesley and Ashley Graham, making it the most valuable UK-founded drinks brand since Innocent and Fever-Tree.
Company data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Founded
2019
Employees
50–100
Total Funding
$40M
2 rounds
Latest Valuation
$0.3B
November 2025
Total raised $40M across 2 rounds
Funding data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Last updated 06-25-2026
Latest Round
Type
Growth
Date
November 2025
Amount
$40M
Valuation
$0.3B
Lead Investors
| Date | Round | Amount Raised | Valuation | Lead Investors |
|---|---|---|---|---|
| November 2025 | Growth | $40M | $0.3B | Coefficient Capital |
| 2024 | Late-stage / Growth | Not disclosed | $0.25B | Not disclosed |
Olivia Ferdi
Co-Founder & CEO
Daniel Khoury
Co-Founder
Competitor list is illustrative and may be incomplete, stale, or erroneous.
Recess
New York-based functional sparkling water and powders brand that launched in 2018 with hemp-derived CBD beverages and has since expanded into adaptogen and nootropic mood drinks; one of Trip's most directly comparable US competitors in the calming-beverage category.
Kin Euphorics
Los Angeles-based non-alcoholic functional beverage brand co-founded by Jen Batchelor and Bella Hadid, offering nootropic and adaptogenic 'euphoric' drinks positioned as alcohol alternatives competing with Trip's mood-and-mindset positioning.
Cann
US cannabis-infused social tonic brand offering low-dose THC/CBD sparkling beverages aimed at the same wellness-and-social-drinking occasions Trip targets in the calming/functional category.
Moment
Functional, adaptogen- and botanical-infused still and sparkling waters marketed for calm and focus; a direct shelf competitor to Trip in US natural-channel retailers.
De Soi
Katy Perry-co-founded non-alcoholic apéritif brand using adaptogens and botanicals, competing with Trip in the broader functional / better-for-you adult beverage occasion.
Fever-Tree
London-listed premium mixer and adult-soft-drinks company (LON:FEVR) frequently cited as a UK consumer-drinks comparable for Trip; the most-valuable-UK-drinks-brand-since-Fever-Tree framing was used by founders following the 2025 round.
No. TRIP is a private company and does not have a public stock ticker or trade on a public stock exchange. Its shares are generally held by founders, employees, investors, and other private shareholders. Buyers and sellers may be able to transact in TRIP shares through private secondary transactions, but any transaction depends on share availability, buyer and seller agreement, transfer restrictions, company approval rights, and any applicable right of first refusal. There is no guarantee that TRIP will complete an IPO or other liquidity event.
Yes, it is sometimes possible to buy TRIP shares pre-IPO through private secondary transactions. This depends on finding a willing seller, company approval, and satisfying any transfer restrictions or rights of first refusal.
Buyers interested in buying TRIP shares on the secondary market typically do so through SetterVC and other secondary-market platforms, subject to eligibility requirements, share availability, transfer restrictions, and issuer approval. Buyers may need to satisfy sophistication, accreditation, institutional, platform, regulatory, or other eligibility requirements before participating. Once eligible, buyers may be able to view listings, make bids, and work with a licensed broker through the transaction process. Buyers should ensure they have appropriate legal and financial advisors guiding them before completing any transaction.
The company's latest round valuation was approximately $300M as of November 2025. The latest round valuation is often used as one reference point in secondary-market pricing, but secondary prices may be above or below that valuation at any given time. Secondary pricing can shift significantly based on post-round conditions, such as changes in company performance, supply-demand dynamics, share class, transaction size, transfer restrictions, or broader market shifts. Any implied valuation from a past round should be confirmed with a broker or through live market listings before relying on it.
TRIP was most recently valued at approximately $300M as of November 2025. This is a private valuation and may differ from secondary pricing. Secondary shares may trade above or below this mark based on various factors. SetterVC and Setter Capital does not verify the accuracy of these valuations. Buyers and sellers should always confirm current valuations before completing any transaction.
TRIP's valuation has changed over time based on funding rounds, tender offers, secondary-market indications, and other reported or collected valuation marks. TRIP's valuation moved from approximately $250M as of 2024 to approximately $300M as of November 2025. This comparison reflects company-level valuation marks and does not represent realized investor returns. Secondary-market prices may differ from these valuations based on share class, transaction size, transfer restrictions, supply and demand, company performance, and broader market conditions. SetterVC and Setter Capital does not verify the accuracy or completeness of valuation data, and buyers and sellers should confirm current information before relying on it.
TRIP's latest disclosed funding round was a Growth round in November 2025. The round raised approximately $40M at an approximately $300M valuation, with Coefficient Capital listed as disclosed lead or major investors. Primary funding rounds are different from secondary transactions: in a primary round, capital goes to the company, while in a secondary transaction, investors buy existing shares from current shareholders. Funding-round data reflects publicly reported or collected information and may be incomplete. The latest round valuation should be confirmed before it is used as a pricing reference.
TRIP has raised approximately $40M in disclosed funding across 2 rounds. These figures reflect primary capital raised by the company and do not include every possible secondary transaction, undisclosed round, debt facility, or private transfer. Reported funding totals can change as new rounds are announced or older round details are corrected. Eligible users can use SetterVC to track TRIP's funding history alongside private-market activity where available.
TRIP's disclosed investors include Coefficient Capital. Investor lists are based on public reporting, company announcements, and collected funding-round data, and may be incomplete. Participation in a prior funding round does not mean those investors are currently buying or selling shares. On SetterVC, eligible users can review TRIP's funding history, valuation history, and private-market activity alongside other venture-backed companies.
TRIP's most-cited competitors include Recess, Kin Euphorics, Cann, Moment, De Soi and Fever-Tree. Investors often compare these companies by sector, product focus, valuation, funding raised, growth signals, investor base, and private-market activity.
Secondary-market demand for TRIP shares can be affected by company performance, revenue growth, profitability, funding history, valuation, investor interest, sector momentum, public-market conditions, expected timing of a liquidity event, and the availability of shares for sale. Demand can also be affected by transfer restrictions, company approval rights, right of first refusal processes, limited information, and the price expectations of buyers and sellers. Strong demand does not guarantee strong pricing, liquidity, or investment returns. Weak demand does not necessarily reflect the company's long-term prospects. Demand signals should not be treated as a recommendation or prediction of investment performance. Buyers and sellers should treat demand signals as informational and conduct their own diligence before transacting.
Sellers often rely on intermediaries and platforms, such as SetterVC and other secondary-market platforms, to identify potential buyers. The exact process varies by company and transaction, but sellers often begin by confirming their ownership, desired price, transferability, and any company approval or notice requirements. If the seller agrees with a buyer on acceptable price and terms, the company may need to be notified through a share transfer notice or similar process. If a right of first refusal, company approval right, or other transfer restriction applies, the seller may need to wait until that process is completed. The parties may then execute a purchase and sale agreement, complete required transfer documentation, and close if all required conditions are satisfied. Sellers should always seek proper legal and financial advice before completing the transaction.
Yes, current and former TRIP employees, early investors, and other existing shareholders may be able to sell vested shares before an IPO through a private secondary sale. This is not automatic; it depends on whether the shareholder has transferable shares, whether there is buyer demand, and whether the company's governing documents permit the transfer. Many companies require prior notice, company approval, or a right of first refusal before shares can be sold. Sellers should also seek proper legal and financial advice before proceeding.
A TRIP secondary transaction usually involves an existing shareholder selling shares to a buyer before a public listing. The buyer and seller typically agree on price, number of shares, share class, and closing conditions. The seller may then need to notify TRIP through a share transfer notice or similar process. If TRIP or existing investors have approval rights, transfer restrictions, or a right of first refusal, those steps may need to be completed before the transfer can close. The parties typically enter into a purchase and sale agreement, complete any required transfer documentation, and close only if the necessary conditions are satisfied. Timing and certainty can vary by company and transaction.
In most private secondary transactions, parties commonly use a purchase and sale agreement that outlines price, terms, and conditions. They may also use share transfer documentation, often a stock transfer notice, share transfer notice, transfer instruction, or similar document, along with any required company approval or right of first refusal materials. Proof of ownership, such as a cap table entry, share certificate, brokerage statement, issuer confirmation, or administrator confirmation, may also be important. Buyers often request recent company financials, but private companies may limit disclosure. Since every deal varies, buyers and sellers should consult legal and financial advisors to understand which documents are needed.
Buying TRIP shares pre-IPO is risky. Shares are illiquid, no IPO or liquidity event is guaranteed, valuations can change, transfers may require company approval, and private companies may provide limited financial disclosure. Be prepared for total loss. SetterVC and Setter Capital do not provide due diligence, legal, tax, accounting, valuation, or investment advice. Buyers must conduct their own due diligence, verify information, and seek independent legal and investment advice before proceeding.
Private secondary shares are typically illiquid. Unlike public stocks, there is no active public market, so selling them can be difficult and time-consuming. Sales depend on finding a willing buyer and often require company approval. Investors should be prepared to hold the shares for an extended period, with no guarantee of a future sale. Always assess your need for liquidity before investing.
SetterVC and Setter Capital do not provide due diligence, legal, tax, accounting, valuation, or investment advice. Buyers must conduct their own due diligence, including verifying ownership, transferability, legal structure, company approval, and assessing the company's prospects. SetterVC and Setter Capital do not provide advice on whether an investment is good, what price to pay, or what the best bid or ask is. SetterVC and Setter Capital may share documents in some circumstances, but it does not guarantee their accuracy or completeness. Due diligence is essential. Seek legal and investment advice as needed.
Before buying TRIP shares, a buyer should try to review the share class, price per share, implied valuation, transfer restrictions, ROFR process, company approval rights, seller ownership evidence, recent financing or tender-offer information, available financial information, information rights, resale restrictions, tax considerations, and expected liquidity paths. Not all information may be available for a private company. Buyers should confirm available diligence, process details, and information needs with their own legal, tax, and investment advisers.
SPVs carry risks. Examples include the need to confirm the company allows SPV-based transfers, verify that the SPV truly owns the shares or interests it claims to own, and ensure it has not sold more interests than it holds. Due diligence is essential. Seek legal and investment advice as needed.
Forward contracts carry risks. Examples include the seller refusing to transfer the shares at the future date, even if the seller owns them, the seller going bankrupt with creditors claiming the shares, or the seller committing the same shares to multiple parties. Due diligence is essential. Seek legal and investment advice as needed.
Access live market data
Sign UpData collected with AI, which can make mistakes. Please double-check this information.